These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21189368)

  • 21. [A case of cytomegalovirus colitis during chemotherapy for esophageal cancer].
    Kitahara M; Kanekiyo S; Yamamoto T; Watanabe Y; Takeda S; Ueno T; Yoshino S; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2127-9. PubMed ID: 24394035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E; Karaoglu A
    Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report.
    Ciszek M; Mucha K; Foroncewicz B; Chmura A; Pączek L
    Ann Transplant; 2014 Jan; 19():60-3. PubMed ID: 24481271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory ulcerative colitis complicated by a cytomegaloviral infection requiring surgery: report of a case.
    Nakamura T; Nakamura R; Maruyama K; Fukazawa A; Uno A; Hayashi T; Higashi Y; Hosoda Y; Nakamura S
    Surg Today; 2004; 34(1):68-71. PubMed ID: 14714233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics.
    Caldés A; Gil-Vernet S; Armendariz Y; Colom H; Pou L; Niubó J; Lladó L; Torras J; Manito N; Rufí G; Grinyó JM
    Transpl Infect Dis; 2010 Jun; 12(3):204-12. PubMed ID: 20002612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Generalized intestinal CMV infection with protein-losing syndrome in ulcerative colitis].
    Kraus M; Meyenberger C; Suter W
    Schweiz Med Wochenschr; 2000 Oct; 130(43):1600-5. PubMed ID: 11100513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical manifestations and course of cytomegalovirus colitis in AIDS patients].
    Giezendanner S; Wirth HP; Zala G; Weber R; Flury R; Meyenberger C
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2417-22. PubMed ID: 8553029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T; Busca A; Locatelli F; Falda M; Pittaluga F; Ghisetti V
    J Antimicrob Chemother; 2009 Mar; 63(3):600-8. PubMed ID: 19147520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary CMV colitis in an immunocompetent infant, successfully treated by gancyclovir.
    Abdulhannan P; Sugarman ID; Wood P; Puntis JW
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):203-5. PubMed ID: 18664875
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review.
    Lee CY; Chen YH; Lu PL
    BMC Infect Dis; 2017 Feb; 17(1):113. PubMed ID: 28143418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
    Garcia Compean D; Ramos Jimenez J; Guzman de la Garza F; Saenz C; Maldonado H; Barragan RF; Michel H
    AIDS; 1994 Nov; 8(11):1563-7. PubMed ID: 7848592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
    Cascinu S; Fedeli A; Fedeli SL; Catalano G
    J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
    Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral valganciclovir.
    Subramanian V; Finlayson C; Harrison T; Rice P; Pollok R
    J Crohns Colitis; 2010 Jun; 4(2):199-202. PubMed ID: 21122506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
    Zidan J; Haim N; Beny A; Stein M; Gez E; Kuten A
    Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient--a case report.
    Wang TJ; Lin CP; Yang CM; Lin LL
    Transplant Proc; 2004 Nov; 36(9):2826-9. PubMed ID: 15621160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.